BRCTF logo

BRCTF BioArctic AB

Other OTC · Biotechnology · Healthcare

$30.10
+0.00 (+0.00%)

BioArctic AB (publ) develops biological drugs for patients with central nervous system disorders in Sweden. It engages in the research and development of innovative biological drugs, such as antibodies that address high unmet medical needs. The company’s therapeutic areas encompass neurodegenerative disorders, such as Alzheimer’s disease, Parkinson’s disease, and other CNS diseases. In addition, i…

Market Cap: $2.67Bwww.bioarctic.se

Price

No data yet.

Social Signal Score

43
5d
30
1 mentions
—
30d
45
2 mentions
—
60d
45
2 mentions
—
90d
53
4 mentions
—
news: 4

Revenue

$247.53M+20841.20%
$1.18M$430.66M$860.14M$1.29B
Sep 2016Jun 2026

Analyst Estimates

FY2025
$11.20
$8.72–$14.56
1 analysts
FY2026
$5.67-49% YoY
$4.42–$7.38
1 analysts
FY2027
$6.81+20% YoY
$5.31–$8.86
1 analysts

Consensus estimates, not results. Via Financial Modeling Prep.

Company Profile

CEO
Gunilla Christina Osswald
Sector
Healthcare
Industry
Biotechnology
Employees
131
Beta
-0.67
Country
SE
Piotroski score
4 / 9 (Middling)
Altman Z-score
22.05
www.bioarctic.se